Ocugen reconvenes special shareholder meeting, adjourns vote on authorized share increase proposal
OCGN•Ocugen adjourned its special shareholder meeting to Oct. 26, 2026, deferring a vote on a proposal to increase authorized common shares by 250 million.
1. Vote deferred
Ocugen’s special stockholder meeting reconvened on Oct. 5, 2026, but shareholders did not adopt the proposed amendment to increase authorized common shares by 250 million. The meeting was adjourned to Oct. 26 to allow more time for consideration and voting.
